A detailed history of Meridian Financial Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Meridian Financial Partners LLC holds 1,140 shares of LLY stock, worth $1.16 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,140
Previous 1,073 6.24%
Holding current value
$1.16 Million
Previous $836,000 3.95%
% of portfolio
0.37%
Previous 0.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$625.65 - $812.69 $41,918 - $54,450
67 Added 6.24%
1,140 $869,000
Q2 2025

Aug 07, 2025

BUY
$713.71 - $898.95 $18,556 - $23,372
26 Added 2.48%
1,073 $836,000
Q1 2025

Apr 14, 2025

BUY
$725.72 - $929.72 $759,828 - $973,416
1,047 New
1,047 $865,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Meridian Financial Partners LLC Portfolio

Follow Meridian Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Financial Partners LLC with notifications on news.